MedTech Resources

Company

Infobionic

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$109M

6 Form D offerings, 2012 to 2023

Equity

$108M

Stock sold for cash

Debt and convertible notes

$1.2M

$1.2M of it convertible

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: equity, $57.8M raised of $65.4M sought, first sale Sep 29, 2023, 30 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Sep 29, 2023Equity$57.8M$65.4M30Rule 506(b)Form D ↗Oct 11, 2023
Jul 27, 2018Equity$23.9M$23.9M53Rule 506(b)Form D ↗Aug 14, 2018
Jul 24, 2015Equity$8.2M$8.5M55Rule 506(b)Form D/A ↗Jul 20, 20161 amendment
Mar 28, 2014Equity$17.0M$17.0M70Rule 506(b)Form D/A ↗Nov 21, 20142 amendments
Jun 7, 2013Convertible note$1.2M$2.0M33Rule 506(b)Form D ↗Nov 19, 2013
Dec 12, 2012Equity$969K$969K29Rule 506Form D ↗Dec 20, 2012

Company details

From the company's latest Form D.

Legal name
InfoBionic, Inc.
Headquarters
Chelmsford, Massachusetts
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

  • Peter NoseworthyDirector
  • Gerardo IbarraExecutive Officer, Director
  • Stuart LongExecutive Officer, Director
  • Adrian SteckelDirector
  • David MacCutcheonExecutive Officer
  • Caleb WinderDirector

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

No 5%+ shareholder filings or SBIR grants found under the name Infobionic.

Latest FDA decisions

Search the Clearance Tracker

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

No device trials list this company as lead sponsor.

Reports received

1

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

0

0.0% of reports

Injury reports

0

0.0% of reports

Death reports

1

100% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230000
Jan 240000
Feb 240000
Mar 240000
Apr 240000
May 240000
Jun 240000
Jul 240000
Aug 240000
Sep 240000
Oct 240000
Nov 240000
Dec 240000
Jan 250000
Feb 250000
Mar 250000
Apr 250000
May 250000
Jun 250000
Jul 250000
Aug 250000
Sep 250000
Oct 250000
Nov 250000
Dec 250000
Jan 260000
Feb 260000
Mar 260000
Apr 260000
May 260000
Jun 260000
Jul 260000
Aug 260010
Sep 260000
Oct 260000
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recalls under this name in FDA's data.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.